Geepenil Vet. Stungulyfsstofn og leysir, lausn 24 g Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

geepenil vet. stungulyfsstofn og leysir, lausn 24 g

orion corporation - benzylpenicillinum natríum - stungulyfsstofn og leysir, lausn - 24 g

Streptocillin vet. Stungulyf, dreifa Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

streptocillin vet. stungulyf, dreifa

boehringer ingelheim animal health nordics a/s - benzylpenicillinprocainum; dihydrostreptomycinum súlfat - stungulyf, dreifa

Penovet vet. Stungulyf, dreifa 300 .000 a.e./ml Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

penovet vet. stungulyf, dreifa 300 .000 a.e./ml

boehringer ingelheim animal health nordics a/s - benzylpenicillinprocainum - stungulyf, dreifa - 300 .000 a.e./ml

Depomycine, vet. Stungulyf, dreifa Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

depomycine, vet. stungulyf, dreifa

intervet international b.v.* - benzylpenicillinprocainum; dihydrostreptomycinum súlfat - stungulyf, dreifa

Benestermycin vet. Spenalyf, smyrsli Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

benestermycin vet. spenalyf, smyrsli

boehringer ingelheim vetmedica gmbh* - framycetinum súlfat; benethaminum penicillinum inn; penethamate hydroiodide ban - spenalyf, smyrsli

Tibsovo Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - Æxlishemjandi lyf - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.